Chemotherapy-induced peripheral neuropathies in hematological malignancies Joost Louis Marie JongenAnnemiek BroijlPieter Sonneveld Topic Review 19 October 2014 Pages: 229 - 237
Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells Shingo TanakaMitsutoshi NakadaAtsushi Hirao Laboratory Investigation 08 October 2014 Pages: 239 - 250
PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment Dimitrios MathiosJacob RuzevickMichael Lim Laboratory Investigation 28 October 2014 Pages: 251 - 259
The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome Lei ZhangYong YanXiaojun Wu Laboratory Investigation 31 October 2014 Pages: 261 - 268
Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas Kristin SchneiderAstrid WeyerbrockMarcia Regina Machein Laboratory Investigation 05 November 2014 Pages: 269 - 278
Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway Yuewen ChaoYan WangXiuping Zhou Laboratory Investigation 06 November 2014 Pages: 279 - 288
Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system Ariz AkhterNoraidah MasirAdnan Mansoor Laboratory Investigation 13 November 2014 Pages: 289 - 296
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas Andrew D. NordenDavid SchiffPatrick Y. Wen Clinical Study 22 October 2014 Pages: 297 - 302
Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme? Amr AminM. MustafaE. Saad Clinical Study 28 October 2014 Pages: 303 - 309
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume Hong Rye KimSe-Hwan KimDoo-Sik Kong Clinical Study 09 December 2014 Pages: 311 - 318
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme Martin K. HunnEvelyn BauerIan F. Hermans Clinical Study 31 October 2014 Pages: 319 - 329
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab Qiuting WenLaleh JalilianSarah J. Nelson Clinical Study Open access 29 October 2014 Pages: 331 - 339
Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2 Tobias WalbertTito R. MendozaTerri S. Armstrong Clinical Study 31 October 2014 Pages: 341 - 348
Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma Moran ArtziDeborah T. BlumenthalDafna Ben Bashat Clinical Study 05 November 2014 Pages: 349 - 357
The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme Lola B. ChamblessHeather M. KistkaReid C. Thompson Clinical Study 26 October 2014 Pages: 359 - 364
Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics Walter TaalCarin C. D. van der RijtMartin J. van den Bent Clinical Study 26 October 2014 Pages: 365 - 372
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab Philipp KickingerederBenedikt WiestlerAlexander Radbruch Clinical Study 31 October 2014 Pages: 373 - 380
Expert-validated CSF segmentation of MNI atlas enhances accuracy of virtual glioma growth patterns A. AmelotE. StrettonE. Mandonnet Clinical Study 05 November 2014 Pages: 381 - 387
Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy Damien C. WeberCarmen AresRalf Schneider Clinical Study 02 November 2014 Pages: 389 - 397
Post progression survival in glioblastoma: where are we? Enrico FranceschiMario ErmaniAlba A. Brandes Clinical Study 01 November 2014 Pages: 399 - 404
Single agent vinorelbine in pediatric patients with progressive optic pathway glioma Andrea Maria CappellanoAntonio Sergio PetrilliEric Bouffet Clinical Study 01 November 2014 Pages: 405 - 412
Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology Tae-Young JungJi Yeoun LeeSeung-Ki Kim Clinical Study 04 November 2014 Pages: 413 - 419
Diffusion weighted MRI is a promising imaging biomarker in brain metastases R. ZakariaM. D. Jenkinson Letter to the Editor Open access 30 October 2014 Pages: 421 - 422
Comment on “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460] Thomas C. BoothAdam D. WaldmanRolf Jäger Letter to the Editor 01 November 2014 Pages: 423 - 424
